Literature DB >> 19114656

A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN.

Meghdad Rahdar1, Takanari Inoue, Tobias Meyer, Jin Zhang, Francisca Vazquez, Peter N Devreotes.   

Abstract

The PI 3-phosphatase PTEN (phosphatase and tensin homologue deleted on chromosome 10), one of the most important tumor suppressors, must associate with the plasma membrane to maintain appropriate steady-state levels of phosphatidylinositol 3,4,5-triphosphate. Yet the mechanism of membrane binding has received little attention and the key determinants that regulate localization, a phosphatidylinositol 4,5-bisphosphate (PIP(2)) binding motif and a cluster of phosphorylated C-terminal residues, were not included in the crystal structure. We report that membrane binding requires PIP(2) and show that phosphorylation regulates an intramolecular interaction. A truncated version of the enzyme, PTEN(1-351), bound strongly to the membrane, an effect that was reversed by co-expression of the remainder of the molecule, PTEN(352-403). The separate fragments associated in vitro, an interaction dependent on phosphorylation of the C-terminal cluster, a portion of the PIP(2) binding motif, integrity of the phosphatase domain, and the CBR3 loop. Our investigation provides direct evidence for a model in which PTEN switches between open and closed states and phosphorylation favors the closed conformation, thereby regulating localization and function. Small molecules targeting these interactions could potentially serve as therapeutic agents in antagonizing Ras or PI3K-driven tumors. The study also stresses the importance of determining the structure of the native enzyme.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19114656      PMCID: PMC2626728          DOI: 10.1073/pnas.0811212106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Phosphorylation of the PTEN tail regulates protein stability and function.

Authors:  F Vazquez; S Ramaswamy; N Nakamura; W R Sellers
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

2.  The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation.

Authors:  J Torres; R Pulido
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

3.  Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex.

Authors:  F Vazquez; S R Grossman; Y Takahashi; M V Rokas; N Nakamura; W R Sellers
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

4.  Tumor suppressor PTEN mediates sensing of chemoattractant gradients.

Authors:  Miho Iijima; Peter Devreotes
Journal:  Cell       Date:  2002-05-31       Impact factor: 41.582

5.  Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor.

Authors:  M M Georgescu; K H Kirsch; P Kaloudis; H Yang; N P Pavletich; H Hanafusa
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

6.  Reversible inactivation of the tumor suppressor PTEN by H2O2.

Authors:  Seung-Rock Lee; Kap-Seok Yang; Jaeyul Kwon; Chunghee Lee; Woojin Jeong; Sue Goo Rhee
Journal:  J Biol Chem       Date:  2002-03-26       Impact factor: 5.157

7.  Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.

Authors:  J O Lee; H Yang; M M Georgescu; A Di Cristofano; T Maehama; Y Shi; J E Dixon; P Pandolfi; N P Pavletich
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

8.  Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases.

Authors:  J Liliental; S Y Moon; R Lesche; R Mamillapalli; D Li; Y Zheng; H Sun; H Wu
Journal:  Curr Biol       Date:  2000-04-06       Impact factor: 10.834

Review 9.  Protean PTEN: form and function.

Authors:  Kristin A Waite; Charis Eng
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

10.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

View more
  133 in total

1.  The PTEN Tumor Suppressor Forms Homodimers in Solution.

Authors:  Frank Heinrich; Srinivas Chakravarthy; Hirsh Nanda; Antonella Papa; Pier Paolo Pandolfi; Alonzo H Ross; Rakesh K Harishchandra; Arne Gericke; Mathias Lösche
Journal:  Structure       Date:  2015-08-20       Impact factor: 5.006

2.  PTEN activation through K163 acetylation by inhibiting HDAC6 contributes to tumour inhibition.

Authors:  Z Meng; L-F Jia; Y-H Gan
Journal:  Oncogene       Date:  2015-08-17       Impact factor: 9.867

3.  Phosphorylation keeps PTEN phosphatase closed for business.

Authors:  Alonzo H Ross; Arne Gericke
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

4.  Therapeutic targeting of cancers with loss of PTEN function.

Authors:  Lloye M Dillon; Todd W Miller
Journal:  Curr Drug Targets       Date:  2014-01       Impact factor: 3.465

Review 5.  PTEN function: the long and the short of it.

Authors:  Benjamin D Hopkins; Cindy Hodakoski; Douglas Barrows; Sarah M Mense; Ramon E Parsons
Journal:  Trends Biochem Sci       Date:  2014-03-18       Impact factor: 13.807

6.  A pathogenic role for germline PTEN variants which accumulate into the nucleus.

Authors:  Janire Mingo; Isabel Rodríguez-Escudero; Sandra Luna; Teresa Fernández-Acero; Laura Amo; Amy R Jonasson; Roberto T Zori; José I López; María Molina; Víctor J Cid; Rafael Pulido
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

7.  A motor driving PTEN.

Authors:  Jing Zhou; Luis F Parada
Journal:  Nat Cell Biol       Date:  2009-10       Impact factor: 28.824

Review 8.  The role of phosphoinositides in synapse function.

Authors:  Yoshibumi Ueda
Journal:  Mol Neurobiol       Date:  2014-06-17       Impact factor: 5.590

9.  Protein Chemical Approaches to Understanding PTEN Lipid Phosphatase Regulation.

Authors:  Daniel R Dempsey; Philip A Cole
Journal:  Methods Enzymol       Date:  2018-06-30       Impact factor: 1.600

10.  SUMO, PTEN and Tumor Suppression.

Authors:  Michael J Matunis; Catherine M Guzzo
Journal:  Pigment Cell Melanoma Res       Date:  2012-07-31       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.